Beneficial effects of quercetin on renal injury and oxidative stress caused by ciprofloxacin in rats

Human and Experimental Toxicology

Volumn 35, Issue 3, 2016, Pages 276-281

  Elbe, H ^a   Dogan, Z ^b   Taslidere, E ^c   Cetin, A ^c   Turkoz, Y ^c  

^a MUGLA SITKI KOCMAN UNIVERSITY   (Turkey)

^b ADIYAMAN UNIVERSITY   (Turkey)

^c INONU UNIVERSITY   (Turkey)

Author keywords

Ciprofloxacin; oxidative stress; quercetin; renal injury

Indexed keywords

CATALASE; CIPROFLOXACIN; GLUTATHIONE; MALONALDEHYDE; QUERCETIN; SUPEROXIDE DISMUTASE; ANTIINFECTIVE AGENT; ANTIOXIDANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOWMAN CAPSULE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; KIDNEY HEMORRHAGE; KIDNEY INJURY; KIDNEY NECROSIS; KIDNEY PARENCHYMA; KIDNEY TUBULE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECTS; KIDNEY; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; CATALASE; CIPROFLOXACIN; FEMALE; GLUTATHIONE; KIDNEY; MALONDIALDEHYDE; OXIDATIVE STRESS; QUERCETIN; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 84957616516     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327115584686     Document Type: Article

References (32)

1. Naeem U, Waheed A, Bakhtlar S,. Determination of the effects of ciprofloxacin in prevention of aminoglycoside induced nephrotoxicity in rabbits: a comparative study. Pak J Pharmacol 2010; 27: 1-10.
2. Halawa A,. Effect of ciprofloxacin on the articular cartilage and epiphyseal growth plate cartilage in the growing albino rats and the possible protective role of vitamine (α-tocopherol): a histological and morphometric study. Egypt J Histol 2010; 33: 569-582.
3. Mohanasundaram J, Mohanasundaram S,. Effect of duration of treatment on ciprofloxacin induced arthropathy in young rats. Indian J Pharmacol 2001; 3: 100-103.
4. Adikwu E, Brambaifa N,. Ciprofloxacin cardiotoxicity and hepatotoxicity in humans and animals. Pharmacol Pharm 2012; 3: 207-213.
5. Lomaestro BM,. Fluoroquinolone-induced renal failure. Drug Saf 2000; 22 (6): 479-485.
6. Bird ST, Etminan M, Brophy JM, et al. Risk of acute kidney injury associated with the use of fluoroquinolones. CMAJ 2013; 185 (10): 475-482.
7. Kanter M, Altan MF, Donmez S, et al. The effects of quercetin on bone minerals, biomechanical behavior, and structure in streptozotocin-induced diabetic rats. Cell Biochem Funct 2007; 25: 747-752.
8. Coskun O, Kanter M, Korkmaz A, et al. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol Res 2005; 51: 117-123.
9. Liu C-M, Zheng Y-L, Lu J, et al. Quercetin protects rat liver against lead-induced oxidative stress and apoptosis. Environ Toxicol Pharmacol 2010; 29: 158-166.
10. Sanders RA, Rauscher FM, Watkins JB III,. Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 2001; 15: 143-149.
11. Coldiron AD Jr., Sanders RA, Watkins JB III,. Effects of combined quercetin and coenzyme Q10 treatment on oxidative stress in normal and diabetic rats. J Biochem Mol Toxicol 2002; 16: 197-202.
12. Uchiyama M, Mihara M,. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978; 86 (1): 271-278.
13. Elman GL,. Tissue sulphydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
14. Sun Y, Oberly LW, Li Y,. A simple method for clinical assay of SOD. Clin Chem 1988; 34: 479-500.
15. Lowry O, Rosenbraugh N, Farr L, et al. Protein measurement with the folin-phenol reagent. J Biol Chem 1951; 183: 265-275.
16. Casado A, de La Torre R, Lopéz-Fernández E,. Antioxidant enzyme levels in red blood cells from cataract patients. Gerontology 2001; 47: 186-188.
17. Rawi SM, Mourad IM, Arafa NMS, et al. Effect of ciprofloxacin and levofloxacin on some oxidative stress parameters in brain regions of male albino rats. Afr J Pharm Pharmacol 2011; 5 (16): 1888-1897.
18. Stahlmann R,. Clinical toxicological aspects of fluoroquinolones. Toxicol Lett 2002; 127: 269-277.
19. Khaki A, Heidari M, Novin MG, et al. Adverse effects of ciprofloxacin on testis apoptosis and sperm parameters in rats. Iran J Reprod Med 2008; 6 (2): 71-76.
20. Christ W, Lehnert T, Ulbrich B,. Specific toxicological aspects of the quinolones. Rev Infec Dis 1991; 10 (1): 141-146.
21. Pannu N, Nadim MK,. An overview of drug-induced acute kidney injury. Crit Care Med 2008; 36: 216-223.
22. Al-Shawi NN,. Possible histological changes induced by therapeutic doses of ciprofloxacin in liver and kidney of juvenile rats. Pharmacologia 2012; 3 (9): 477-480.
23. Gurbay A, Garrel C, Osman M, et al. Cytotoxicity in ciprofloxacin-treated human fibroblast cells and protection by vitamin E. Hum Exp Toxicol 2002; 21 (12): 635-641.
24. Gurbay A, Osman M, Favier A, et al. Ciprofloxacin-induced cytotoxicity and apoptosis in HeLa cells. Toxicol Mech Meth 2005; 15: 339-342.
25. Gurbay A, Gonthier B, Signorini-Allibe N, et al. Ciprofloxacin induced DNA damage in primary culture of rat astrocytes and protection by vitamin E. NeuroToxicology 2006; 27: 6-10.
26. Gurbay A, Gonthier B, Barret L, et al. Cytotoxic effect of ciprofloxacin in primary culture of rat astrocytes and protection by vitamin E. Toxicology 2007; 229 (1-2): 54-61.
27. Becerra MC, Albesa I,. Oxidative stress induced by ciprofloxacin in Staphylococcus aureus. Biochem Biophys Res Commun 2002; 297: 1003-1007.
28. Hincal F, Gurbay A, Favier A,. Biphasic response of ciprofloxacin in human fibroblast cell cultures. Nonlinearity Biol Toxicol Med 2003; 1 (4): 481-492.
29. Esrefoglu M, Mustafa Iraz M, Ates B, et al. Melatonin and CAPE are able to prevent the liver from oxidative damage in rats: an ultrastructural and biochemical study. Ultrastruct Pathol 2012; 36 (3): 171-178.
30. Kurus M, Esrefoglu M, Karabulut AB, et al. Oral l -arginine protects against cyclosporine-induced hepatotoxicity in rats. Exp Toxicol Pathol 2008; 60: 411-419.
31. Mates JM, Perez-Gomez C, Castro IN,. Antioxidant enzymes and human diseases. Clin Biochem 1999; 32 (8): 595-603.
32. Gurbay A, Gonthier B, Daveloose D, et al. Microsomal metabolism of ciprofloxacin generates free radicals. Free Radic Biol Med 2001; 30 (10): 1118-1121.